Incidence of Complete Posterior Vitreous Detachment After Trabeculectomy.
1 other identifier
interventional
46
1 country
1
Brief Summary
Intraocular surgery could induce vitreous degeneration and posterior vitreous detachment (PVD). Vitreomacular interface (VMI) abnormalities usually are caused by abnormal PVD, vitreoschisis and partial-thickness PVD. Furthermore, the PVD could induce the peripheral break. The incidence of peripheral break and epimacular membrane (EMM) after pneumatic retinopexy were 11.7% and 4-11%, respectively. Although multiple intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections induced PVD of 5.6%, but peripheral break was reported as only 0.67%. The most common intraocular surgery is cataract surgery. From the literature review, many methods were used to detect the PVD after phacoemulsification. The former studies used indirect ophthalmoscopy and ocular ultrasound for diagnosis of PVD. The later studies used the optical coherence tomography (OCT) for PVD detection. The OCT device had higher effectiveness in evaluation of the posterior segment, then it can detect post-phacoemulsification PVD more and early than previous studies. Ivastinovic et al demonstrated 59.2% of patients had PVD at 1 month after phacoemulsification, and increased up to 71.4% at 3 months. The incidence of rhegmatogenous retinal detachment (RRD) after phacoemulsification is gradually increased with time. The accumulative risk of RRD was increased from 0.27% at 1 year to 1.27% at 20 years after phacoemulsification.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 23, 2021
CompletedFirst Posted
Study publicly available on registry
January 27, 2021
CompletedStudy Start
First participant enrolled
July 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedJune 30, 2021
June 1, 2021
2.5 years
January 23, 2021
June 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of PVD
complete PVD
12 months
Secondary Outcomes (1)
The incidence of VMI abnormalities
12 months
Study Arms (1)
Glaucoma patients who was scheduled for trabeculectomy
OTHERWide-field OCT was performed 1-2 weeks before the trabeculectomy. The OCT was done postoperatively at 1 month, 3 months, 6 months and 12 months after surgery.
Interventions
Merged 4 images of wide-field optical coherence tomography, 2 images of vertical scan and 2 images of horizontal scan.
Eligibility Criteria
You may qualify if:
- Primary open angle glaucoma or primary angle closure glaucoma
- Age 18-65 years
- Could be taken the wide-field OCT images
- Written informed consent
You may not qualify if:
- History of intraocular inflammation or infection
- History of ocular trauma or head trauma
- History of intraocular surgery such as intravitreal drug injection and cataract surgery
- History of vitreoretinal diseases such as diabetic retinopathy, retinal vascular occlusion and age-related macular degeneration
- History of laser treatment including laser capsulotomy and retinal photocoagulation
- High myopia; spherical equivalence \>4 diopters
- Complete PVD was detected before the enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Khon Kaen University
Khon Kaen, 40002, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Suthasinee Sinawat, MD
KKU Eye Center, Department of Ophthalmology, Faculty of Medicine, Khon Kaen University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- KKU Eye Center, Department of Ophthalmology
Study Record Dates
First Submitted
January 23, 2021
First Posted
January 27, 2021
Study Start
July 1, 2021
Primary Completion
December 30, 2023
Study Completion
June 30, 2024
Last Updated
June 30, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share